TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/31/22 17:36 | 5/26/22 | RIVN | Rivian Automotive, Inc. / De | DE | Auto | Auto | Motor Vehicles & Passenger Ca | Flatley Jay T | CA | D | P | 1,172 | 29.31 | 0 | 40 | 76 | 93 | D | |||||||||||||||
11/19/21 16:30 | 11/17/21 | ZY | Zymergen Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Flatley Jay T | CA | DO | CB,Actin | P | 1,000 | 10.00 | 0 | 100 | 223 | 145 | D | ||||||||||||||
11/17/21 19:47 | 11/15/21 | RIVN | Rivian Automotive, Inc. / De | DE | Auto | Auto | Motor Vehicles & Passenger Ca | Flatley Jay T | CA | D | P | 1,560 | 78.00 | 0 | 20 | 61 | 53 | D | |||||||||||||||
1/30/18 16:29 | 5/30/17 | JUNO | Juno Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Flatley Jay T | WA | D | P | 229 | 22.92 | 0 | 10 | 47 | 32 | I | |||||||||||||||
5/26/17 18:04 | 5/24/17 | JUNO | Juno Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Flatley Jay T | WA | D | P.m | 495 | 24.76 | 0 | 20 | 999% | 22 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |